ReverseScreen.ai: Pharmacophore-Guided Reverse Screening Across the Growing Co-Complex Proteome
Biopharmaceutical companies routinely use forward screening to identify potential ligands for argets of biological consequence. Increasingly, they are also using reverse screening to proactively identify downstream off-target liabilities and new repurposing opportunities. Exhaustive reverse docking of one or a multitud...